Histone deacetylase (HDAC) inhibitors when combined with a proteasome inhibitor are safe and effective in patients with extranodal natural killer/T-cell lymphoma (ENKTL).
Raffles Cancer Centre, Raffles Hospital, Singapore tan_daryl@rafflesmedical.com.
D
D
Tan
Department of Haematology, Singapore General Hospital, Singapore, Republic of Singapore.
C P
CP
Diong
Raffles Cancer Centre, Raffles Hospital, Singapore.
Y
Y
Loh
Department of Haematology, Singapore General Hospital, Singapore, Republic of Singapore.
Y T
YT
Goh
D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases; D006801:Humans; D054391:Lymphoma, Extranodal NK-T-Cell; D055611:Natural Killer T-Cells; D061988:Proteasome Inhibitors
D056572:Histone Deacetylase Inhibitors; D061988:Proteasome Inhibitors; D006655:Histone Deacetylases